Restasis Emulsion
Product Images NDC 50090-4476

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Restasis (NDC 50090-4476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904476)

Label for RESTASIS ophthalmic emulsion with cyclosporine 0.5 mg/mL, manufactured by A-S Medication Solutions. It specifies the product NDC 50090-4476-0 and package containing 30 single-use vials of 0.4 mL each. Storage instructions indicate to keep the product at 59 to 77 degrees Fahrenheit.*

FDA Label Image

The Following Structure For Restasis® (cyclosporine Ophthalmic Emulsion) 0.05% Contains A Topical Calcineurin Inhibitor Immunosuppressant With Anti-inflammatory Effects. Cyclosporine’s Chemical Name Is Cyclo[[(e)-(2s,3r,4r)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-l-2-aminobutyryl-n-methylglycyl-n-methyl-l-leucyl-l-valyl-n-methyl-l-leucyl-l-alanyl-d-alanyl-n-methyl-l-leucyl-n-methyl-l-leucyl-n-methyl-l-valyl]. (Restasis 01)

Chemical structure diagram of cyclosporine, the active ingredient in RESTASIS 0.5 mg/mL ophthalmic emulsion by A-S Medication Solutions.*

FDA Label Image

Allergan (Restasis 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.